Cancer Immunology Research,
Journal Year:
2024,
Volume and Issue:
12(7), P. 854 - 875
Published: April 26, 2024
Abstract
Glutamine
metabolism
in
tumor
microenvironments
critically
regulates
antitumor
immunity.
Using
the
glutamine-antagonist
prodrug
JHU083,
we
report
potent
growth
inhibition
urologic
tumors
by
JHU083-reprogrammed
tumor-associated
macrophages
(TAMs)
and
tumor-infiltrating
monocytes.
We
show
JHU083-mediated
glutamine
antagonism
induced
TNF,
proinflammatory,
mTORC1
signaling
intratumoral
TAM
clusters.
TAMs
also
exhibited
increased
cell
phagocytosis
diminished
proangiogenic
capacities.
In
vivo
of
consumption
resulted
glycolysis,
a
broken
tricarboxylic
acid
(TCA)
cycle,
purine
disruption.
Although
effect
on
T
cells
was
moderate,
JHU083
promoted
stem
cell–like
phenotype
CD8+
decreased
abundance
regulatory
cells.
Finally,
caused
global
shutdown
glutamine-utilizing
metabolic
pathways
cells,
leading
to
reduced
HIF-1α,
c-MYC
phosphorylation,
induction
apoptosis,
all
key
features.
Altogether,
our
findings
demonstrate
that
targeting
with
led
suppressed
as
well
reprogramming
immunosuppressive
within
prostate
bladder
immune
responses.
can
offer
an
effective
therapeutic
benefit
for
types
are
enriched
TAMs.
Cancer Immunology Research,
Journal Year:
2023,
Volume and Issue:
11(4), P. 405 - 420
Published: Jan. 18, 2023
Abstract
Patients
with
colorectal
liver
metastasis
(CLM)
present
heterogenous
clinical
outcomes
and
improved
classification
is
needed
to
ameliorate
the
therapeutic
output.
Macrophages
(Mϕ)
hold
promise
as
prognostic
classifiers
targets.
Here,
stemming
from
a
single-cell
analysis
of
mononuclear
phagocytes
infiltrating
human
CLM,
we
identified
two
Mϕ
markers
associated
distinct
populations
opposite
relevance.
The
invasive
margin
CLM
was
enriched
in
pro-inflammatory
monocyte-derived
(MoMϕ)
expressing
monocytic
marker
SERPINB2,
more
differentiated
population,
tumor-associated
(TAM),
glycoprotein
nonmetastatic
melanoma
protein
B
(GPNMB).
SERPINB2+
MoMϕ
had
an
early
inflammatory
profile,
whereas
GPNMB+
TAMs
were
pathways
matrix
degradation,
angiogenesis,
lipid
metabolism
found
closer
tumor
margin,
confirmed
by
spatial
transcriptomics
on
specimens.
In
cohort
patients,
high
infiltration
cells
independently
longer
disease-free
survival
(DFS;
P
=
0.033),
density
correlated
shorter
DFS
(P
0.012)
overall
0.002).
Cell–cell
interaction
defined
opposing
roles
for
TAMs,
suggesting
that
are
discrete
may
be
exploited
further
translation
immune-based
stratification
tool.
This
study
provides
evidence
how
multi-omics
approaches
can
identify
nonredundant,
clinically
relevant
patient
tools
GPNMB
has
been
shown
set
immunosuppressive
mode.
Our
dimensional
analyses
provide
negative
indicator
potential
player
protumor
function
populations.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: June 29, 2023
Cellular
metabolism
plays
a
critical
role
in
determining
the
fate
and
function
of
cells.
Metabolic
reprogramming
its
byproducts
have
complex
impact
on
cellular
activities.
In
quiescent
T
cells,
oxidative
phosphorylation
(OXPHOS)
is
primary
pathway
for
survival.
However,
upon
antigen
activation,
cells
undergo
rapid
metabolic
reprogramming,
characterized
by
an
elevation
both
glycolysis
OXPHOS.
While
pathways
are
induced,
balance
predominantly
shifts
towards
glycolysis,
enabling
to
rapidly
proliferate
enhance
their
functionality,
representing
most
distinctive
signature
during
activation.
processes
generate
various
small
molecules
resulting
from
enzyme-catalyzed
reactions,
which
also
modulate
protein
exert
regulatory
control.
Notably,
recent
studies
revealed
direct
modification
histones,
known
as
lactylation,
lactate
derived
glycolysis.
This
lactylation
process
influences
gene
transcription
adds
novel
variable
regulation
expression.
Protein
has
been
identified
essential
mechanism
exerts
diverse
functions,
contributing
crucial
biological
such
uterine
remodeling,
tumor
proliferation,
neural
system
regulation,
regulation.
review
focuses
explores
interplay
between
immune
system,
highlights
function,
elucidates
intersection
epigenetics.
EMBO Reports,
Journal Year:
2024,
Volume and Issue:
25(2), P. 471 - 488
Published: Jan. 12, 2024
Abstract
Tumor
cells
reprogram
nutrient
acquisition
and
metabolic
pathways
to
meet
their
energetic,
biosynthetic,
redox
demands.
Similarly,
processes
in
immune
support
host
immunity
against
cancer
determine
differentiation
fate
of
leukocytes.
Thus,
deregulation
imbalance
within
the
tumor
microenvironment
have
been
reported
drive
evasion
compromise
therapeutic
outcomes.
Interestingly,
emerging
evidence
indicates
that
anti-tumor
could
modulate
heterogeneity,
aggressiveness,
reprogramming,
suggesting
immunosurveillance
can
instruct
progression
multiple
dimensions.
This
review
summarizes
our
current
understanding
how
crosstalk
tumors
affects
immunogenicity
promotes
progression.
Furthermore,
we
explain
defects
cascade
contribute
developing
dysfunctional
responses
cancers
discuss
contribution
these
as
a
feedback
mechanism.
Finally,
highlight
ongoing
clinical
trials
new
strategies
targeting
cellular
metabolism
cancer.
Cancer Immunology Research,
Journal Year:
2024,
Volume and Issue:
12(7), P. 854 - 875
Published: April 26, 2024
Abstract
Glutamine
metabolism
in
tumor
microenvironments
critically
regulates
antitumor
immunity.
Using
the
glutamine-antagonist
prodrug
JHU083,
we
report
potent
growth
inhibition
urologic
tumors
by
JHU083-reprogrammed
tumor-associated
macrophages
(TAMs)
and
tumor-infiltrating
monocytes.
We
show
JHU083-mediated
glutamine
antagonism
induced
TNF,
proinflammatory,
mTORC1
signaling
intratumoral
TAM
clusters.
TAMs
also
exhibited
increased
cell
phagocytosis
diminished
proangiogenic
capacities.
In
vivo
of
consumption
resulted
glycolysis,
a
broken
tricarboxylic
acid
(TCA)
cycle,
purine
disruption.
Although
effect
on
T
cells
was
moderate,
JHU083
promoted
stem
cell–like
phenotype
CD8+
decreased
abundance
regulatory
cells.
Finally,
caused
global
shutdown
glutamine-utilizing
metabolic
pathways
cells,
leading
to
reduced
HIF-1α,
c-MYC
phosphorylation,
induction
apoptosis,
all
key
features.
Altogether,
our
findings
demonstrate
that
targeting
with
led
suppressed
as
well
reprogramming
immunosuppressive
within
prostate
bladder
immune
responses.
can
offer
an
effective
therapeutic
benefit
for
types
are
enriched
TAMs.